Stimuli responsive drug delivery systems based on nano-graphene for cancer therapy

2016 ◽  
Vol 105 ◽  
pp. 228-241 ◽  
Author(s):  
Kai Yang ◽  
Liangzhu Feng ◽  
Zhuang Liu
Keyword(s):  
Drug Delivery ◽  
Cancer Therapy ◽  
Drug Delivery Systems ◽  
Delivery Systems ◽  
Stimuli Responsive ◽  
Nano Graphene

Stimuli-Responsive Nano-Drug Delivery Systems for Cancer Therapy

2020 ◽  
pp. 151-162
Author(s):  
Sauraj ◽  
Anuj Kumar ◽  
Bijender Kumar ◽  
Ruchir Priyadarshi ◽  
Chhavi Sharma ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Cancer Therapy ◽  
Drug Delivery Systems ◽  
Delivery Systems ◽  
Stimuli Responsive ◽  
Nano Drug Delivery

scholarly journals Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy

2021 ◽  
Vol Volume 16 ◽  
pp. 1525-1551
Author(s):  
Ruixin Jia ◽  
Lesheng Teng ◽  
Lingyu Gao ◽  
Ting Su ◽  
Lu Fu ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Cancer Therapy ◽  
Drug Delivery Systems ◽  
Delivery Systems ◽  
Stimuli Responsive

scholarly journals Stimuli-responsive drug delivery systems for head and neck cancer therapy

Drug Delivery ◽  
2021 ◽  
Vol 28 (1) ◽  
pp. 272-284
Author(s):  
Jingou Liang ◽  
Bina Yang ◽  
Xuedong Zhou ◽  
Qi Han ◽  
Jing Zou ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Head And Neck Cancer ◽  
Cancer Therapy ◽  
Head And Neck ◽  
Neck Cancer ◽  
Drug Delivery Systems ◽  
Delivery Systems ◽  
Stimuli Responsive

scholarly journals Smart stimuli-responsive nanocarriers for the cancer therapy – nanomedicine

2021 ◽  
Vol 10 (1) ◽  
pp. 933-953
Author(s):  
Baranya Murugan ◽  
Suresh Sagadevan ◽  
Is Fatimah ◽  
Won-Chun Oh ◽  
Mohd Abd Motalib Hossain ◽  
...  
Keyword(s):  
Magnetic Field ◽  
Drug Delivery ◽  
Controlled Release ◽  
Cancer Therapy ◽  
Drug Delivery Systems ◽  
Delivery Systems ◽  
Release Profile ◽  
Acidic Ph ◽  
Stimuli Responsive ◽  
External Stimuli

Abstract Nanomedicine is ongoing current research in the applications of nanotechnology for cancer therapy. Simply from a technology perspective, this field of research has an enormous broadening and success to date. Recently, nanomedicine has also made inroads in the treatment of cancer. Stimuli-responsive nanoparticles are an emerging field of research because its targeting capacity is of great interest in the treatment of cancer. The responsive nanoparticles are efficient in encountering different internal biological stimuli (acidic, pH, redox, and enzyme) and external stimuli (temperature, ultrasounds, magnetic field, and light), which are used as smart nanocarriers for delivery of the chemotherapeutic and imaging agents for cancer therapy. In-depth, the responsive nanocarrier that responds to the biological cues is of pronounced interest due to its capability to provide a controlled release profile at the tumor-specific site. The outlook of this review focuses on the stimuli-responsive nanocarrier drug delivery systems in sequence to address the biological challenges that need to be evaluated to overcome conventional cancer therapy.

Supramolecular Nanomedicine Derived from Cucurbit[7]uril-Conjugated Nano-Graphene Oxide for Multi-modality Cancer Therapy

2021 ◽  
Author(s):  
Yuan-Fu Ding ◽  
Cheryl Kwong ◽  
Shengke Li ◽  
Yating Pan ◽  
Jianwen Wei ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Graphene Oxide ◽  
Cancer Therapy ◽  
Surface Functionalization ◽  
Drug Delivery Systems ◽  
Drug Loading ◽  
Delivery Systems ◽  
Π Stacking ◽  
Nano Graphene

Nano-graphene oxide (NGO) has attracted increasing attentions as advanced drug delivery systems. However, the current surface functionalization and drug-loading of NGO either relies on π−π stacking that is limited to...

Nanoparticle-based Drug Delivery Systems for Targeted Epigenetics Cancer Therapy

2020 ◽  
Vol 21 (11) ◽  
pp. 1084-1098
Author(s):  
Fengqian Chen ◽  
Yunzhen Shi ◽  
Jinming Zhang ◽  
Qi Liu
Keyword(s):  
Drug Delivery ◽  
Side Effects ◽  
Cancer Therapy ◽  
Drug Delivery Systems ◽  
Therapeutic Index ◽  
Delivery Systems ◽  
Epigenetic Therapy ◽  
Cancer Therapies ◽  
Therapeutic Benefits ◽  
High Therapeutic Index

This review summarizes the epigenetic mechanisms of deoxyribonucleic acid (DNA) methylation, histone modifications in cancer and the epigenetic modifications in cancer therapy. Due to their undesired side effects, the use of epigenetic drugs as chemo-drugs in cancer therapies is limited. The drug delivery system opens a door for minimizing these side effects and achieving greater therapeutic benefits. The limitations of current epigenetic therapies in clinical cancer treatment and the advantages of using drug delivery systems for epigenetic agents are also discussed. Combining drug delivery systems with epigenetic therapy is a promising approach to reaching a high therapeutic index and minimizing the side effects.

Sign in / Sign up

Export Citation Format

Share Document